# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Arcadia Biosciences (NASDAQ:RKDA) with a Buy and maintains $10...
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.10) per share which beat the analyst consensus estimate of $...
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...
-- Three flavor varieties fiber up the beloved boxed classic, delivering amazing taste with a Mac that's good for your gut,...
The Dow Jones index closed lower by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their c...